Charlottesville, VA, United States of America

Guoquan Wang

USPTO Granted Patents = 18 

 

 

Average Co-Inventor Count = 2.9

ph-index = 6

Forward Citations = 191(Granted Patents)


Location History:

  • Charlottesville, VA (US) (2008 - 2017)
  • Crozet, VA (US) (2017)

Company Filing History:


Years Active: 2008-2017

Loading Chart...
Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents

Title: Guoquan Wang: Innovator in Pharmaceutical Chemistry

Introduction

Guoquan Wang is a prominent inventor based in Charlottesville, VA, known for his significant contributions to pharmaceutical chemistry. With a total of 18 patents to his name, he has made remarkable advancements in the field of adenosine receptor research.

Latest Patents

His latest patents include innovative compounds such as N-alkyl 2-(disubstituted)alkynyladenosine-5'-uronamides and derivatives, which serve as selective agonists of adenosine receptors (ARs). These compounds and their pharmaceutical compositions are poised to be valuable agents in medical applications. Another notable patent involves xanthine-substituted alkynyl carbamates and reverse carbamates, which act as selective antagonists of adenosine receptors. These inventions also hold promise as pharmaceutical agents.

Career Highlights

Throughout his career, Guoquan Wang has worked with several companies, including Pgxhealth, LLC and Lewis and Clark Pharmaceuticals, Inc. His work has significantly impacted the development of new therapeutic agents.

Collaborations

He has collaborated with notable professionals in the field, including Robert Douglas Thompson and Jayson Michael Rieger, further enhancing the scope of his research and innovations.

Conclusion

Guoquan Wang's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a leading inventor in the industry. His work continues to influence the development of new medical therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…